![[SIGN thistle header]](../../../../images/page-header-template.jpg)
|
|
Guideline
topic: Pharmacological management of asthma |
||||||||
| Author |
Year |
Study type |
Quality rating |
Population |
Outomes measured |
Effect size |
Confidence intervals / p values |
Comments |
|
| Adults |
|||||||||
| Gong1 |
1990 |
Randomised, double-blind, placebo-controlled, cross-over. Single dosing with cetirizine 5mg, 10mg and 20mg, and salbutamol 4mg. |
++ |
10 adults with asthma |
Exercise-induced bronchoconstriction % fall in FEV1 |
|
|
Both oral cetrizine and salbutamol had no effect on EIA. |
|
| Young people |
|||||||||
| Sly2 |
1982 |
Randomised,
double-blind, placebo-controlled, cross-over. |
++ |
18 children age 12-18 with asthma |
Exercise-induced bronchoconstriction % fall in FEV1 |
Placebo: 38% Terbutaline: 11% |
p<0.05 |
Oral terbutaline had a significant protective effect against EIA. Part of this effect may be due to an increas in base FEV1 prior to exercise. |
|